Explore

Trendline Trendline
BioMarin Expands Rare Disease Treatment Portfolio with Amicus Acquisition

BioMarin Expands Rare Disease Treatment Portfolio with Amicus Acquisition

BioMarin Expands Rare Disease Treatment Portfolio with Amicus Acquisition
Trendline Trendline
BioMarin Expands Communications Strategy with New Associate Director Role

BioMarin Expands Communications Strategy with New Associate Director Role

BioMarin Expands Communications Strategy with New Associate Director Role
Trendline Trendline
BioMarin Announces Strong Q2 2026 Financial Results and Increased Revenue Guidance

BioMarin Announces Strong Q2 2026 Financial Results and Increased Revenue Guidance

BioMarin Announces Strong Q2 2026 Financial Results and Increased Revenue Guidance
Trendline Trendline
INmune Bio Advances Ebstracel for RDEB with UK Regulatory Alignment

INmune Bio Advances Ebstracel for RDEB with UK Regulatory Alignment

INmune Bio Advances Ebstracel for RDEB with UK Regulatory Alignment
Trendline Trendline
Flagship Pioneering's FL116 Seeks Senior Manager to Drive Biotech Innovation

Flagship Pioneering's FL116 Seeks Senior Manager to Drive Biotech Innovation

Flagship Pioneering's FL116 Seeks Senior Manager to Drive Biotech Innovation
Trendline Trendline
X-Linked Retinitis Pigmentosa Market Set for Growth with Gene Therapy Advancements

X-Linked Retinitis Pigmentosa Market Set for Growth with Gene Therapy Advancements

X-Linked Retinitis Pigmentosa Market Set for Growth with Gene Therapy Advancements
Trendline Trendline
OmniAb Increases 2026 Revenue Outlook Amid Strong Q2 Financial Results

OmniAb Increases 2026 Revenue Outlook Amid Strong Q2 Financial Results

OmniAb Increases 2026 Revenue Outlook Amid Strong Q2 Financial Results
Trendline Trendline
Dycom Industries Offers Competitive Benefits for Business Analyst Role

Dycom Industries Offers Competitive Benefits for Business Analyst Role

Dycom Industries Offers Competitive Benefits for Business Analyst Role
Trendline Trendline
Evommune Announces Financial Results and Advances in Inflammatory Disease Therapies

Evommune Announces Financial Results and Advances in Inflammatory Disease Therapies

Evommune Announces Financial Results and Advances in Inflammatory Disease Therapies
Trendline Trendline
Advancements in Microscopy: New Tools and Techniques in Imaging

Advancements in Microscopy: New Tools and Techniques in Imaging

Advancements in Microscopy: New Tools and Techniques in Imaging
Trendline Trendline
AbCellera Reports Q2 2026 Results with New Collaborations and Financial Challenges

AbCellera Reports Q2 2026 Results with New Collaborations and Financial Challenges

AbCellera Reports Q2 2026 Results with New Collaborations and Financial Challenges
Trendline Trendline
Sarepta Therapeutics Reports Strong Profitability Amid Revenue Decline in Q2 2026

Sarepta Therapeutics Reports Strong Profitability Amid Revenue Decline in Q2 2026

Sarepta Therapeutics Reports Strong Profitability Amid Revenue Decline in Q2 2026